| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |